Skip to content

Pathological and biological assessment of arterial thrombus retrieved from infarct-related artery in patients with or without atrial fibrillation

Pathological and biological assessment of arterial thrombus retrieved from infarct-related artery in patients with or without atrial fibrillation - Macrophage in thrombus study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041615
Enrollment
100
Registered
2020-08-31
Start date
2019-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke and acute myocardial infarction

Interventions

None listed

Sponsors

National Hospital Organization Mito Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: stroke within 6 hours from symptom onset, acute myocardial infarction within 12 hours from symptom onset, successfully retrieved thrombus from infarct-related artery

Exclusion criteria

Exclusion criteria: hepatic disease, renal failure(eGFR<30), active malignancy, collagen disease, contraindication of emergent catheter treatment, not suitable for the inclusion judged by operator.

Design outcomes

Primary

MeasureTime frame
Distribution of M1, M2 macrophage in thrombus

Secondary

MeasureTime frame
classification of thrombus defined as follows; fresh, lytic, organized, markers in thrombus, biomarkers in serum

Countries

Japan

Contacts

Public ContactTomomi Koizumi

National Hospital Organization Mito Medical Center Division of Cardiovascular Medicine

tkoizumioffice@gmail.com+81292407711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026